The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...

Genomic technologies have the potential to transform the management of infectious diseases. In Pathogen Genomics Into Practice we set out a roadmap to converting the power of this exciting new ...

Dr. Pete Mills is responsible for providing leadership and strategic direction to the PHG Foundation in its mission to make science work for health. He works closely with the wider team and external ...

The information held within our genes and how it can be used to improve individual health, continues to generate excitement amongst researchers, health professionals and policymakers. The potential to ...

The sepsis definition describes three elements: infection, the host response and life-threatening organ dysfunction. Diagnosis is made based on myriad signs and symptoms, and although infection ...

Continued improvements in computing power and techniques means that health services are beginning to experience the benefits that machine learning has to offer. From supporting healthcare ...

Rebecca is responsible for delivering integrated communications strategies for PHG Foundation. She works closely with policy analysts to plan, design and deliver relevant, accessible, and engaging ...

Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...

Our experienced staff, trustees and associates bring their specialist knowledge from a wide range of backgrounds to create interdisciplinary policy solutions to the practical challenges of translating ...

In Artificial intelligence for genomic medicine we examine the intersection between AI and genomics, the drivers behind the recent rise of AI techniques for genomics and outline existing and emerging ...

Dr. Chantal Babb de Villiers uses her expertise in genetics, healthcare, diagnostics, and epidemiology to contribute to many PHG Foundation projects including polygenic scores and technology ...

This strategy forms the basis for our approach between 2025 and 2030. Throughout this period, we will work with researchers, health professionals and policy makers, and across the commercial, ...